Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
Emcure Pharmaceuticals
Namita Thapar's Investment Grows 38,200% As Emcure Pharma Lists At 31% Premium On NSE
Emcure Pharmaceuticals' stock listing on NSE at 31% premium has resulted in a huge growth of Namita Thapar's investment from ₹ 2.19 crore to ₹ 653 crore.
Namita Thapar's Investment Grows 38,200% As Emcure Pharma Lists At 31% Premium On NSE
